`Trials@uspto.gov
`Entered: December 20, 2018
`Tel: 571-272-7822
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`TARO PHARMACEUTICALS U.S.A., INC.,
`Petitioner,
`v.
`APOTEX TECHNOLOGIES, INC.,
`Patent Owner.
`
`Case IPR2017-01446
`Patent 7,049,328 B2
`
`
`Before JEFFREY N. FREDMAN, ZHENYU YANG, and
`MICHELLE N. ANKENBRAND, Administrative Patent Judges.
`
`FREDMAN, Administrative Patent Judge.
`
`
`
`
`ORDER
`Granting Patent Owner’s Motion to Expunge
`37 C.F.R. § 42.5
`
`
`On December 12, 2018, Patent Owner filed a Motion to Expunge
`Confidential Information (“Motion”). Paper 66. Specifically, Patent Owner
`requests expungement of Exhibits 1037–1043 and 1047–1049, all filed
`under seal. Id. at 1. Patent Owner represents that Petitioner does not oppose
`the Motion. Id. at 1 n.1.
`
`
`
`IPR2017-01446
`Patent 7,049,328 B2
`
`
`On August 6, 2018, pursuant to 35 U.S.C. § 317(a), the parties filed a
`Joint Motion to Terminate this proceeding. Paper 61. In light of the parties’
`settlement, we entered an order terminating the proceeding. Paper 65. We
`did not rely on any information in the aforementioned exhibits to dispose of
`any issues in this proceeding. Our review of these exhibits indicates that
`they do contain nonpublic information.
`Based on the record before us, the need to protect the confidential
`information in Exhibits 1037–1043 and 1047–1049 outweighs the public
`interest in unsealing those exhibits. Accordingly, it is appropriate to
`expunge the exhibits from the record.
`It is:
`ORDERED that Exhibits 1037–1043 and 1047–1049 be expunged
`from the record.
`
`
`2
`
`
`
`IPR2017-01446
`Patent 7,049,328 B2
`
`
`
`PETITIONER:
`Huiya Wu
`Sara Fink
`GOODWIN PROCTER LLP
`hwu@goodwinlaw.com
`sfink@goodwinlaw.com
`
`PTENT OWNER:
`W. Blake Coblentz
`Aaron S. Lukas
`COZEN O’CONNOR
`WCoblentz@cozen.com
`ALukas@cozen.com
`
`3
`
`